Annual Revenue
$14.60 K
-$31.00 K-67.98%
December 31, 2022
Summary
- As of February 8, 2025, NAVB annual revenue is $14.60 thousand, with the most recent change of -$31.00 thousand (-67.98%) on December 31, 2022.
- During the last 3 years, NAVB annual revenue has fallen by -$12.00 thousand (-45.11%).
- NAVB annual revenue is now -99.85% below its all-time high of $9.71 million, reached on December 31, 2000.
Performance
NAVB Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
N/A
September 30, 2023
Summary
- NAVB quarterly revenue is not available.
Performance
NAVB Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
September 30, 2023
Summary
- NAVB TTM revenue is not available.
Performance
NAVB TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
NAVB Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -68.0% | - | - |
| 3 y3 years | -45.1% | - | - |
| 5 y5 years | -86.6% | - | - |
NAVB Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -68.0% | at low | ||||
| 5 y | 5-year | -87.7% | at low | ||||
| alltime | all time | -99.8% | at low |
Navidea Biopharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $14.60 K(-68.0%) | $600.00(-92.0%) | $14.60 K(-2.0%) |
| Sep 2022 | - | $7500.00(+15.4%) | $14.90 K(-9.7%) |
| Jun 2022 | - | $6500.00(+622.2%) | $16.50 K(-63.8%) |
| Dec 2021 | $45.60 K(-61.6%) | $900.00(-90.1%) | $45.60 K(-65.6%) |
| Sep 2021 | - | $9100.00(-30.5%) | $132.50 K(+1.8%) |
| Jun 2021 | - | $13.10 K(-41.8%) | $130.20 K(+3.3%) |
| Mar 2021 | - | $22.50 K(-74.4%) | $126.00 K(+6.1%) |
| Dec 2020 | $118.70 K(+346.2%) | $87.80 K(+1191.2%) | $118.70 K(+253.3%) |
| Sep 2020 | - | $6800.00(-23.6%) | $33.60 K(+6.0%) |
| Jun 2020 | - | $8900.00(-41.4%) | $31.70 K(-18.1%) |
| Mar 2020 | - | $15.20 K(+463.0%) | $38.70 K(+44.9%) |
| Dec 2019 | $26.60 K(-91.8%) | $2700.00(-44.9%) | $26.70 K(-54.7%) |
| Sep 2019 | - | $4900.00(-69.2%) | $59.00 K(-22.8%) |
| Jun 2019 | - | $15.90 K(+396.9%) | $76.40 K(-76.5%) |
| Mar 2019 | - | $3200.00(-90.9%) | $324.90 K(+0.7%) |
| Dec 2018 | $322.50 K(+195.6%) | $35.00 K(+57.0%) | $322.50 K(+8.7%) |
| Sep 2018 | - | $22.30 K(-91.6%) | $296.60 K(+8.1%) |
| Jun 2018 | - | $264.40 K(>+9900.0%) | $274.30 K(+149.6%) |
| Mar 2018 | - | $800.00(-91.2%) | $109.90 K(+0.7%) |
| Dec 2017 | $109.10 K(-94.1%) | $9100.00(-90.9%) | $109.10 K(-160.5%) |
| Jun 2017 | - | $100.00 K(-104.8%) | -$180.40 K(-109.8%) |
| Dec 2016 | $1.84 M(+59.3%) | -$2.10 M(-215.4%) | $1.84 M(-147.5%) |
| Sep 2016 | - | $1.82 M(+56.3%) | -$3.86 M(+126.2%) |
| Jun 2016 | - | $1.17 M(+23.1%) | -$1.71 M(>+9900.0%) |
| Mar 2016 | - | $948.50 K(-112.2%) | -$7500.00(-100.7%) |
| Dec 2015 | $1.15 M(-81.6%) | -$7.80 M(-296.1%) | $1.15 M(-89.7%) |
| Sep 2015 | - | $3.98 M(+38.8%) | $11.15 M(+18.3%) |
| Jun 2015 | - | $2.87 M(+36.0%) | $9.42 M(+23.5%) |
| Mar 2015 | - | $2.11 M(-4.1%) | $7.63 M(+21.6%) |
| Dec 2014 | $6.27 M(+455.0%) | $2.20 M(-2.3%) | $6.27 M(+36.1%) |
| Sep 2014 | - | $2.25 M(+109.4%) | $4.61 M(+67.0%) |
| Jun 2014 | - | $1.07 M(+43.0%) | $2.76 M(+46.7%) |
| Mar 2014 | - | $751.80 K(+40.5%) | $1.88 M(+66.5%) |
| Dec 2013 | $1.13 M(+1336.6%) | $535.00 K(+33.6%) | $1.13 M(+87.7%) |
| Sep 2013 | - | $400.40 K(+105.0%) | $602.50 K(+198.1%) |
| Jun 2013 | - | $195.30 K(+2772.1%) | $202.10 K(+156.8%) |
| Dec 2012 | $78.70 K(-86.8%) | $6800.00(-88.7%) | $78.70 K(-76.0%) |
| Jun 2012 | - | $60.00 K(+404.2%) | $327.50 K(+19.7%) |
| Mar 2012 | - | $11.90 K(-95.3%) | $273.60 K(-74.3%) |
| Dec 2011 | $597.70 K(-3.2%) | - | - |
| Sep 2011 | - | $255.60 K(+4090.2%) | $1.07 M(+11.0%) |
| Jun 2011 | - | $6100.00(-98.2%) | $959.50 K(-72.5%) |
| Mar 2011 | - | $336.00 K(-28.2%) | $3.49 M(-40.2%) |
| Dec 2010 | $617.40 K(-93.5%) | $467.80 K(+212.7%) | $5.84 M(-25.3%) |
| Sep 2010 | - | $149.60 K(-94.1%) | $7.82 M(-23.8%) |
| Jun 2010 | - | $2.54 M(-5.4%) | $10.25 M(+7.7%) |
| Mar 2010 | - | $2.68 M(+9.7%) | $9.52 M(+0.0%) |
| Dec 2009 | $9.52 M(+25.4%) | $2.44 M(-5.5%) | $9.52 M(+7.9%) |
| Sep 2009 | - | $2.59 M(+43.4%) | $8.82 M(+9.8%) |
| Jun 2009 | - | $1.80 M(-32.7%) | $8.04 M(-5.3%) |
| Mar 2009 | - | $2.68 M(+53.1%) | $8.49 M(+11.9%) |
| Dec 2008 | $7.59 M(+6.5%) | $1.75 M(-2.7%) | $7.59 M(-1.7%) |
| Sep 2008 | - | $1.80 M(-20.2%) | $7.72 M(-2.3%) |
| Jun 2008 | - | $2.25 M(+26.5%) | $7.90 M(+10.3%) |
| Mar 2008 | - | $1.78 M(-5.1%) | $7.16 M(+0.6%) |
| Dec 2007 | $7.12 M | $1.88 M(-5.3%) | $7.12 M(+0.1%) |
| Sep 2007 | - | $1.99 M(+30.8%) | $7.12 M(+16.9%) |
| Jun 2007 | - | $1.52 M(-13.0%) | $6.09 M(+1.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | $1.74 M(-6.8%) | $6.01 M(-0.7%) |
| Dec 2006 | $6.05 M(+2.2%) | $1.87 M(+95.3%) | $6.05 M(+8.1%) |
| Sep 2006 | - | $958.00 K(-33.2%) | $5.60 M(-6.3%) |
| Jun 2006 | - | $1.43 M(-19.8%) | $5.97 M(-4.3%) |
| Mar 2006 | - | $1.79 M(+26.0%) | $6.24 M(+5.4%) |
| Dec 2005 | $5.92 M(-0.6%) | $1.42 M(+6.4%) | $5.92 M(+2.9%) |
| Sep 2005 | - | $1.33 M(-21.6%) | $5.75 M(-6.4%) |
| Jun 2005 | - | $1.70 M(+16.0%) | $6.15 M(+2.6%) |
| Mar 2005 | - | $1.47 M(+16.9%) | $5.99 M(+0.7%) |
| Dec 2004 | $5.95 M(-8.6%) | $1.25 M(-27.3%) | $5.95 M(-9.7%) |
| Sep 2004 | - | $1.73 M(+11.4%) | $6.59 M(+8.9%) |
| Jun 2004 | - | $1.55 M(+8.6%) | $6.05 M(-5.3%) |
| Mar 2004 | - | $1.43 M(-24.8%) | $6.40 M(-1.7%) |
| Dec 2003 | $6.51 M(+32.3%) | $1.90 M(+59.9%) | $6.51 M(+3.5%) |
| Sep 2003 | - | $1.19 M(-37.3%) | $6.29 M(+4.4%) |
| Jun 2003 | - | $1.89 M(+22.8%) | $6.02 M(+11.6%) |
| Mar 2003 | - | $1.54 M(-8.1%) | $5.40 M(+9.7%) |
| Dec 2002 | $4.92 M(-39.9%) | $1.68 M(+82.2%) | $4.92 M(-8.3%) |
| Sep 2002 | - | $919.80 K(-27.3%) | $5.37 M(-15.7%) |
| Jun 2002 | - | $1.27 M(+19.3%) | $6.37 M(-13.7%) |
| Mar 2002 | - | $1.06 M(-50.1%) | $7.38 M(-7.0%) |
| Dec 2001 | $8.19 M(-15.6%) | $2.12 M(+10.7%) | $7.94 M(-8.0%) |
| Sep 2001 | - | $1.92 M(-15.8%) | $8.63 M(-4.5%) |
| Jun 2001 | - | $2.28 M(+40.6%) | $9.04 M(-4.6%) |
| Mar 2001 | - | $1.62 M(-42.5%) | $9.47 M(-2.4%) |
| Dec 2000 | $9.71 M(+2.8%) | $2.82 M(+21.2%) | $9.71 M(+40.9%) |
| Sep 2000 | - | $2.33 M(-14.3%) | $6.89 M(+50.9%) |
| Jun 2000 | - | $2.71 M(+46.1%) | $4.57 M(+21.6%) |
| Mar 2000 | - | $1.86 M(-2.3%) | $3.76 M(-50.1%) |
| Dec 1999 | $9.45 M(+61.9%) | - | - |
| Jun 1999 | - | $1.90 M(0.0%) | $7.53 M(+8.7%) |
| Mar 1999 | - | $1.90 M(-6.5%) | $6.93 M(+16.9%) |
| Dec 1998 | $5.83 M(+13.7%) | $2.03 M(+19.6%) | $5.93 M(+7.3%) |
| Sep 1998 | - | $1.70 M(+30.8%) | $5.53 M(+7.8%) |
| Jun 1998 | - | $1.30 M(+44.4%) | $5.13 M(+4.1%) |
| Mar 1998 | - | $900.00 K(-44.7%) | $4.93 M(-3.9%) |
| Dec 1997 | $5.13 M(+327.3%) | $1.63 M(+25.2%) | $5.13 M(+25.1%) |
| Sep 1997 | - | $1.30 M(+18.2%) | $4.10 M(+36.7%) |
| Jun 1997 | - | $1.10 M(0.0%) | $3.00 M(+42.9%) |
| Mar 1997 | - | $1.10 M(+83.3%) | $2.10 M(+75.0%) |
| Dec 1996 | $1.20 M(+20.0%) | $600.00 K(+200.0%) | $1.20 M(+33.3%) |
| Sep 1996 | - | $200.00 K(0.0%) | $900.00 K(+12.5%) |
| Jun 1996 | - | $200.00 K(0.0%) | $800.00 K(-11.1%) |
| Mar 1996 | - | $200.00 K(-33.3%) | $900.00 K(-10.0%) |
| Dec 1995 | $1.00 M(+11.1%) | $300.00 K(+200.0%) | $1.00 M(-9.1%) |
| Sep 1995 | - | $100.00 K(-66.7%) | $1.10 M(-8.3%) |
| Jun 1995 | - | $300.00 K(0.0%) | $1.20 M(+9.1%) |
| Mar 1995 | - | $300.00 K(-25.0%) | $1.10 M(+22.2%) |
| Dec 1994 | $900.00 K(+800.0%) | $400.00 K(+100.0%) | $900.00 K(+80.0%) |
| Sep 1994 | - | $200.00 K(0.0%) | $500.00 K(+25.0%) |
| Jun 1994 | - | $200.00 K(+100.0%) | $400.00 K(+33.3%) |
| Mar 1994 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
| Dec 1993 | $100.00 K(0.0%) | - | - |
| Sep 1993 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
| Jun 1993 | - | $100.00 K(0.0%) | $300.00 K(+50.0%) |
| Mar 1993 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| Dec 1992 | $100.00 K | - | - |
| Sep 1992 | - | $100.00 K | $100.00 K |
FAQ
- What is Navidea Biopharmaceuticals annual revenue?
- What is the all time high annual revenue for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals annual revenue year-on-year change?
- What is the all time high quarterly revenue for Navidea Biopharmaceuticals?
- What is the all time high TTM revenue for Navidea Biopharmaceuticals?
What is Navidea Biopharmaceuticals annual revenue?
The current annual revenue of NAVB is $14.60 K
What is the all time high annual revenue for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high annual revenue is $9.71 M
What is Navidea Biopharmaceuticals annual revenue year-on-year change?
Over the past year, NAVB annual revenue has changed by -$31.00 K (-67.98%)
What is the all time high quarterly revenue for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high quarterly revenue is $3.98 M
What is the all time high TTM revenue for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high TTM revenue is $11.15 M